PMID: 6110195Feb 1, 1981

Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?

Neurology
V W Henderson, G F Wooten

Abstract

The neuroleptic malignant syndrome (NMS) of extrapyramidal signs and hyperthermia is an uncommon complication of therapy with the major tranquilizers. Other manifestations are pallor, diaphoresis, blood pressure fluctuation, tachycardia, and tachypneic hypoventilation, which may necessitate respirator support. Death often occurs, but full recovery can result with prompt recognition and proper management. In a patient with Parkinson disease and a chronic psychiatric disorder treated with haloperidol, typical features of NMS appeared upon cessation of dopaminergic antiparkinsonian drugs. Manifestations of NMS are attributed to dopamine receptor blockade in the striatum, increasing thermogenesis, and in the hypothalamus, impairing heat dissipation.

Citations

Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·M E RodriguezJ A Obeso
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·C S Lu, S J Ryu
Jan 1, 1993·Journal of Neural Transmission. General Section·J Kornhuber, M Weller
Jan 1, 1992·Journal of Neural Transmission. General Section·T BrannanM D Yahr
Jan 1, 1991·The Psychiatric Quarterly·M J Akpaffiong, P Ruiz
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·J KornhuberP Riederer
Feb 1, 1989·Italian Journal of Neurological Sciences·L Figà-Talamanca, C Gualandi
Jun 1, 1987·Italian Journal of Neurological Sciences·R SandykC R Bamford
Sep 1, 1994·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·D Kelly, S J Brull
Dec 17, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Edward M MillsJon E Sprague
Mar 1, 1985·Biological Psychiatry·G L Fricchione
Aug 1, 1987·Biological Psychiatry·G AddonizioS D Roth
Apr 1, 1989·Biological Psychiatry·H HermeshJ Eviatar
Feb 1, 1990·Biological Psychiatry·K Nisijima, T Ishiguro
Jul 1, 1990·Biological Psychiatry·P E KeckS L McElroy
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·J N Joyce
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·T F LeeR D Myers
Jan 1, 1984·Pharmacology & Therapeutics·W G Clark, J M Lipton
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·J de LeonI de la Serna
Sep 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·Perminder S Sachdev
Jul 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·S S GratzG M Simpson
Dec 1, 1995·Progress in Neuro-psychopharmacology & Biological Psychiatry·M Amore, N Zazzeri
Apr 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·G SechiG Rosati
Jan 1, 1990·General Pharmacology·M EbadiL C Murrin
Jan 1, 1991·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A DonnetA Alif Cherif
Dec 1, 1995·Journal of Clinical Anesthesia·C C Young, B S Kaufman
May 1, 1989·Disease-a-month : DM·J P Knochel
Aug 1, 1985·Psychosomatics·P S Mueller
Mar 10, 1984·Lancet
Mar 1, 1984·La Revue du praticien·F HilpertP Auzépy
Oct 21, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·G SechiG Rosati
Nov 1, 1996·The Journal of Emergency Medicine·G R Pesola, C Quinto
Oct 23, 1997·Critical Care Clinics·T C ChanR F Clark
Oct 8, 2004·Schizophrenia Research·Terence W H Chong, David J Castle
May 9, 2003·Parkinsonism & Related Disorders·Takao HashimotoNobuo Yanagisawa
May 9, 2003·Parkinsonism & Related Disorders·Hideki TakuboYoshikuni Mizuno
May 9, 2003·Parkinsonism & Related Disorders·Hideki TakuboHirotaro Narabayashi
May 9, 2003·Parkinsonism & Related Disorders·Toshihide HaradaShigenobu Nakamura
May 9, 2003·Parkinsonism & Related Disorders·Yoshikuni MizunoSadako Kuno
Mar 10, 2000·International Journal of Urology : Official Journal of the Japanese Urological Association·Y KunishimaT Tsukamoto
Jul 18, 1985·The New England Journal of Medicine·B H Guzé, L R Baxter
Jan 1, 1987·The Journal of General Psychology·J B Murray
Aug 18, 2012·Journal of Child and Adolescent Psychopharmacology·Katherine M Matheson, Gerald Gray
Aug 2, 2002·Clinical Neuropharmacology·Ronald J Gurrera
Apr 1, 1990·Anaesthesia·J N Montgomery, J W Ironside
Apr 27, 2010·Psychiatry and Clinical Neurosciences·Umit Tural, Emin Onder
Oct 1, 1991·Australian and New Zealand Journal of Medicine·A Henderson, P Longdon
May 12, 1984·British Medical Journal·E Szabadi
Jan 16, 1988·British Medical Journal·T Cassidy, S K Bansal
Mar 28, 1992·BMJ : British Medical Journal·D S RenwickP Bannister
Feb 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·D LefkowitzL C McHenry
Sep 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·M P BarnesC A Kirk
Jul 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·U Tacke, E Venalainen
Jul 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·V KontaxakisV Tserpe
Aug 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·K Kashihara, K Ishida
Aug 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·E M Jones, A Dawson
Jun 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·A V SrinivasanZ A Sayeed
Aug 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·D A Bennett
Mar 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·P F Buckley, M Hutchinson
Apr 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·Y SatoKei Satoh
Jan 1, 1986·Postgraduate Medical Journal·W R Gibb, D N Griffith
Apr 10, 1999·Postgraduate Medical Journal·S A KausarD Mukherjee
Aug 11, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Rebecca E AnglinMichael F Mazurek
Dec 1, 1991·The Australian and New Zealand Journal of Psychiatry·J J ReillyJ H Lloyd
Jun 1, 1996·The Australian and New Zealand Journal of Psychiatry·M M Wong
Dec 18, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·P H Gordon, S J Frucht
Feb 1, 2005·Southern Medical Journal·Ryan C W HallRichard C W Hall
Sep 1, 1994·Italian Journal of Neurological Sciences·A S GabelliniT Sacquegna
Jan 1, 1990·Intensive Care Medicine·P Lenler-PetersenL Hasselstrøm
Aug 3, 2006·Journal of Psychiatric Practice·Dilek MemisJack M Gorman
Jan 1, 1990·The International Journal of Neuroscience·R Sandyk
Jan 1, 1984·Critical Reviews in Clinical Laboratory Sciences·J A Lott, P W Landesman
Jan 1, 1988·The American Journal of Drug and Alcohol Abuse·T R Kosten, H D Kleber
May 1, 1994·Brain Injury : [BI]·M K ChildersD W Smith
Jun 20, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Hubert H FernandezJoseph H Friedman
Nov 2, 2013·Emergency Medicine Clinics of North America·Mary S PadenS Eliza Halcomb
Dec 1, 1985·Psychosomatics·A L PeloneroJ J Silverman
Mar 29, 2006·Clinics in Laboratory Medicine·Daniel E Rusyniak, Jon E Sprague
Jan 1, 1994·The Journal of Emergency Medicine·V Y TottenP Hew
Jul 1, 1991·The American Journal of Emergency Medicine·S M Schneider
Jun 1, 1985·Medical Hypotheses·R Sandyk
Aug 1, 1984·The American Journal of Medicine·G P DowneyM D Aronson
Jan 1, 1985·Comprehensive Psychiatry·L B Greenberg, K Gujavarty
Nov 1, 1989·Acta Anaesthesiologica Scandinavica·P J AdnetB A Dupuis
Dec 1, 1986·Journal of the American Geriatrics Society·M Serby
Jun 1, 1987·Annals of Neurology·D E Bullard
Mar 1, 1987·Acta Psychiatrica Scandinavica·H HermeshA Weizman
Jan 1, 1987·Movement Disorders : Official Journal of the Movement Disorder Society·M R Samie
Apr 1, 1986·Acta Psychiatrica Scandinavica·A Shalev, H Munitz
Nov 1, 1983·Journal of Clinical Pharmacology·W A Price, A J Giannini
Mar 1, 1987·Pharmacology & Toxicology·D NielsenP T Andersen
May 25, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Hisashi TaniiYuji Okazaki
Jan 1, 1988·Neuroscience and Biobehavioral Reviews·M Ebadi, Y Hama
Oct 18, 2005·The Medical Clinics of North America·Daniel E Rusyniak, Jon E Sprague
Apr 18, 2000·Emergency Medicine Clinics of North America·J R Carbone
Mar 1, 2005·The Psychiatric Clinics of North America·Perminder S Sachdev
Jan 1, 1985·International Journal of Psychiatry in Medicine·T ClarkS Dubin
Jan 1, 1984·International Journal of Psychiatry in Medicine·A Stoudemire, J S Luther
Aug 12, 2016·Indian Journal of Anaesthesia·Ankur LuthraKeshav Goyal
Oct 12, 2016·Thérapie·Charles Khourile réseau français des centres régionaux de pharmacovigilance
Mar 16, 2002·The Annals of Pharmacotherapy·Roy R ReevesJohn J Beddingfield
Mar 30, 2001·Journal of Psychopharmacology·M R Turner, N Gainsborough
Sep 8, 2005·European Neurology·Yoshihiro SatoKei Satoh
Jun 1, 1991·Urology·Z KhanV K Singh
Jan 1, 2011·The Neurohospitalist·Brian D Berman
Jun 1, 1987·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P Gaehtgens, P Marx
Jan 1, 1991·Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology·M Nishimura
Jul 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·C S Lu, N S Chu
Aug 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·W R GibbJ Michund
Jan 16, 1988·British Medical Journal·J B Davis
Jan 16, 1988·British Medical Journal·N R Williams
Apr 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·E F Staufenberg, D Tantam
Aug 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·W R Gibb
Dec 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science
Jun 16, 2012·Arquivos de neuro-psiquiatria·Renato P MunhozHélio A G Teive
Apr 26, 2019·The Journal of ECT·Nicholas MorcosDaniel F Maixner
Aug 1, 1989·Journal of Mental Deficiency Research·M R Ward, J A Corbett
Feb 1, 1986·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·M Schibuk, D Schachter
Sep 1, 1983·Drug Intelligence & Clinical Pharmacy·C S Conner
Jun 1, 1988·Drug Intelligence & Clinical Pharmacy·A J WellsM L Crismon
Mar 1, 1984·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J C Morrant
Dec 7, 2017·Der Nervenarzt·R KnorrE Haen
Jan 1, 1989·Journal of Toxicology. Clinical Toxicology·S U Vassallo, K A Delaney
May 1, 1987·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·F PrimeauG Chouinard
Jun 15, 1991·Hospital Practice·P AltusM A Hencey
Feb 1, 1983·Australian and New Zealand Journal of Medicine·J D ScarlettS F Berkovic
Aug 28, 2020·Journal of Community Hospital Internal Medicine Perspectives·Waqas UllahVincent Figueredo
Jun 1, 1987·Journal of the American Geriatrics Society·G L Wergowske, T J Carmody
Jun 1, 1984·Drug Intelligence & Clinical Pharmacy·L J Birkhimer, C L DeVane
Jan 16, 1988·British Medical Journal·E C Paraskevaides
Feb 1, 1984·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·L P Rowland
Mar 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·D AizenbergH Munitz
Oct 1, 1986·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·A Lazarus
Nov 26, 2019·The Journal of ECT·Nicholas MorcosDaniel F Maixner
Sep 16, 1991·The Medical Journal of Australia·A Numa
Apr 17, 1989·The Medical Journal of Australia·C H CantorD Dall'Asen
Jul 1, 1991·The Medical Journal of Australia·D C ReutensP R Goldswain

Related Concepts

Lenticulostriate Disorders
Heat Loss
Macro-Creatine Kinase
Fever
Haldol
Organum Vasculosum Laminae Terminalis
Lithium
Dopamine Receptor
Antipsychotic Effect

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.